All posts by: Michael Zand

About Michael Zand

FDA Approves First Gene Therapy for Hereditary Disease – Healthcare Packaging

Continue reading

2017-12-29 NEWS

Healthcare Packaging

FDA Approves First Gene Therapy for Hereditary Disease
Healthcare Packaging
A December 19thLA Times article reported that the FDA has approved gene therapy to fix mutations that lead to progressive blindness. The drug, Luxturna, is a treatment for retinal dystrophy caused by a genetic mutation. It is the first therapy cleared
Biotech’s Breakthrough YearWall Street Journal

all 2 news articles »

Continue reading

2017-12-29 NEWS

STAT

Stem cell clinics for heart failure: buyer be wary
STAT
e are witnessing great promise in medicine today. The vocabulary dazzles: “precision medicine,” “stem cells,” “moon shot,” and other terms that hint at exciting new possibilities. But it is also a time of great vulnerability for patients. I’m
Stem Cell Leaders Join Frequency Therapeutics’ PCA™ Regenerative Medicine Scientific Advisory BoardBusiness Wire (press release)
Liver Cirrhosis And Stem Cell TherapyCheckbiotech.org (press release)
Global Stem Cell Banking Market Report: Trends and Opportunities for the Industry Forecast over 2022Expert Herald
TMR Research Blog (press release) (blog) –Medgadget (blog) –Digital Journal
all 20 news articles »
Continue reading

2017-12-29 NEWS

HealthWatch: Stem Cells Extend Stroke Treatment Window
WeAreGreenBay.com
He asked if she wanted to be part of a trial for a stem cell treatment that might help her recover. “What this does, the stem cells are from very, very young cells, and they bathe the brain in this environment that makes it act like it’s young again

Continue reading

2017-12-29 NEWS

HeraldScotland

Stem cells help mother with MS make ‘remarkable’ recovery
HeraldScotland
A FORMER marathon runner who has battled multiple sclerosis for more than 20 years said she has made a dramatic recovery since she paid £40,000 for an experimental stem cell treatment in Mexico. Former long distance runner Frances O’Connell, 48, of

and more »